These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 125290
21. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease. Lang JM, Oberling F, Bigel P, Mayer S, Waitz R. Biomedicine; 1974 Sep 20; 21(9):372-7. PubMed ID: 4281669 [No Abstract] [Full Text] [Related]
22. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Miettinen M. Arch Pathol Lab Med; 1992 Nov 20; 116(11):1197-201. PubMed ID: 1332642 [Abstract] [Full Text] [Related]
23. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease. Gajl-Peczalska KJ, Hansen JA, Bloomfield CD, Good RA. J Clin Invest; 1973 Dec 20; 52(12):3064-73. PubMed ID: 4201499 [Abstract] [Full Text] [Related]
24. Lymphocyte function in patients with Hodgkin's disease. Rühl H, Vogt W, Rühl U. G Batteriol Virol Immunol; 1975 Dec 20; 68(1-6):3-16. PubMed ID: 128484 [Abstract] [Full Text] [Related]
25. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease]. Ferrari S, Foggi CM, Serafini NA. Ann Ist Carlo Forlanini; 1968 Dec 20; 28(3):292-309. PubMed ID: 4903142 [No Abstract] [Full Text] [Related]
27. [Malignant lymphomas (non-Hodgkin's lymphomas and Hodgkin's disease) associated with infection by the human immunodeficiency virus. Study of 9 cases]. Lozano-Molero M, Ribera JM, Nomdedeu B, Llebaría C, Campo E, Montserrat E, Rozman C. Med Clin (Barc); 1989 Mar 04; 92(8):302-5. PubMed ID: 2716418 [Abstract] [Full Text] [Related]
28. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Kanavaros P, Vlychou M, Stefanaki K, Rontogianni D, Gaulard P, Pantelidaki E, Zois M, Darivianaki K, Georgoulias V, Boulland ML, Gorgoulis V, Kittas C. Anticancer Res; 1999 Mar 04; 19(2A):1209-16. PubMed ID: 10368677 [Abstract] [Full Text] [Related]
29. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease. Holm G, Björkholm M, Mellstedt H, Nilsson P. J Clin Lab Immunol; 1982 Jan 04; 7(1):51-4. PubMed ID: 6461767 [Abstract] [Full Text] [Related]
30. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Pinkus GS, Said JW. Am J Pathol; 1988 Nov 04; 133(2):211-7. PubMed ID: 3263805 [Abstract] [Full Text] [Related]
31. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma. Sagher D, Karrison T, Schwartz JL, Larson RA, Strauss B. Cancer Res; 1989 Oct 01; 49(19):5339-44. PubMed ID: 2548719 [Abstract] [Full Text] [Related]
32. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G, Onida GA, Piras MA, Marras V, Mura A, Tanda F. Anticancer Res; 1999 Oct 01; 19(5B):3933-8. PubMed ID: 10628334 [Abstract] [Full Text] [Related]
33. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients. Sasiain MC, Fejes M, Ares BR, Brezavscek D, Bachmann AE. Biomedicine; 1981 Oct 01; 35(5):153-6. PubMed ID: 6274439 [Abstract] [Full Text] [Related]
34. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses. Fisher RI, Bates SE, Bostick-Bruton F, Tuteja N, Diehl V. J Immunol; 1984 May 01; 132(5):2672-7. PubMed ID: 6609204 [Abstract] [Full Text] [Related]
35. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells. Imam A, Stathopoulos E, Holland SL, Epstein AL, Taylor CR. Cancer Res; 1990 Mar 01; 50(5):1650-7. PubMed ID: 1689214 [Abstract] [Full Text] [Related]
36. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias. Carella AM, Lerma E, Dejana A, Corsetti MT, Celesti L, Bruni R, Benvenuto F, Figari O, Parodi C, Carlier P, Florio G, Lercari G, Valbonesi M, Casarino L, De Stefano F, Geniram A, Venturino M, Tedeschi L, Palmieri G, Piaggio G, Podestà M, Frassoni F, Van Lint MT, Marmont AM, Bacigalupo A. Haematologica; 1998 Oct 01; 83(10):904-9. PubMed ID: 9830799 [Abstract] [Full Text] [Related]
37. Prostaglandin-producing suppressor cells in Hodgkin's disease. Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC. N Engl J Med; 1977 Nov 03; 297(18):963-8. PubMed ID: 409950 [Abstract] [Full Text] [Related]
38. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease. Pappas A, Pees H, Girmann G. Z Immunitatsforsch Immunobiol; 1977 Apr 03; 153(1):1-10. PubMed ID: 868205 [Abstract] [Full Text] [Related]
39. [Phagocytosis measurement in Hodgkin's disease and Non-Hodgkin lymphoma-patients with a new radiometric assay (author's transl)]. Süss J, Balázs C, Bakács T. Allerg Immunol (Leipz); 1982 Apr 03; 28(1):56-63. PubMed ID: 6214175 [Abstract] [Full Text] [Related]